Product
IMI/REL
Aliases
MK-7655A
1 clinical trial
1 indication
Indication
Gram-negative Bacterial InfectionClinical trial
A Phase 2/3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Than 18 Years of Age With Confirmed or Suspected Gram-negative Bacterial InfectionStatus: Active (not recruiting), Estimated PCD: 2024-06-12